CAP-话题@MedSci

#CAP#

167篇内容 | 3519人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1898018, encodeId=a85a1898018e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=FDA认定rucaparib作为前列腺癌突破性疗法资格, objectType=article, longId=150493, objectId=ac7615049308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac7615049308, replyNumber=0, likeNumber=67, createdTime=2018-12-05, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac7615049308, moduleTitle=FDA认定rucaparib作为前列腺癌突破性疗法资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac7615049308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898027, encodeId=a6f1189802e40, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, objectType=article, longId=159122, objectId=6519159122ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6519159122ab, replyNumber=0, likeNumber=86, createdTime=2019-05-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6519159122ab, moduleTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6519159122ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898014, encodeId=4797189801436, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Medscape：风险工具可能有助于确定哪些肺结节是恶性结节？, objectType=article, longId=133722, objectId=c7c2133e2215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7c2133e2215, replyNumber=0, likeNumber=0, createdTime=2018-07-16, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7c2133e2215, moduleTitle=Medscape：风险工具可能有助于确定哪些肺结节是恶性结节？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7c2133e2215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898013, encodeId=133718980137c, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, objectType=article, longId=132152, objectId=afd513215299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd513215299, replyNumber=0, likeNumber=67, createdTime=2018-07-16, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd513215299, moduleTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd513215299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898023, encodeId=292918980230e, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Medscape盘点｜2018年度心血管领域的Top研究, objectType=article, longId=156616, objectId=a7ec1566161e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7ec1566161e, replyNumber=0, likeNumber=86, createdTime=2019-10-07, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7ec1566161e, moduleTitle=Medscape盘点｜2018年度心血管领域的Top研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7ec1566161e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898024, encodeId=c4eb18980247a, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=血检无异常的酒后腹痛，背后暗藏“杀机”！| Medscape病例分享, objectType=article, longId=157040, objectId=0a1515e0408b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a1515e0408b, replyNumber=0, likeNumber=131, createdTime=2019-10-20, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a1515e0408b, moduleTitle=血检无异常的酒后腹痛，背后暗藏“杀机”！| Medscape病例分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a1515e0408b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898011, encodeId=95731898011f2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Arch Pathol Lab Med.:CAP/IASLC/AMP发布更新的肺癌患者分子检测, objectType=article, longId=128005, objectId=2ff11280058d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ff11280058d, replyNumber=0, likeNumber=59, createdTime=2018-11-07, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ff11280058d, moduleTitle=Arch Pathol Lab Med.:CAP/IASLC/AMP发布更新的肺癌患者分子检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ff11280058d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898017, encodeId=1981189801ebc, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=ANN ONCOL：MiCaP模型可以预测前列腺癌患者术后结局, objectType=article, longId=150029, objectId=4b2215002933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b2215002933, replyNumber=0, likeNumber=58, createdTime=2019-03-08, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b2215002933, moduleTitle=ANN ONCOL：MiCaP模型可以预测前列腺癌患者术后结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b2215002933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898009, encodeId=cb9718980098b, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=J Hepatol：当无创CAP“遇见”酒精性脂肪肝，不仅诊断准确性高，而且…, objectType=article, longId=127149, objectId=ed8812e1496f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8812e1496f, replyNumber=0, likeNumber=72, createdTime=2018-07-10, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8812e1496f, moduleTitle=J Hepatol：当无创CAP“遇见”酒精性脂肪肝，不仅诊断准确性高，而且…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8812e1496f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898022, encodeId=53c7189802231, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Lancet oncol：VR-CAP疗法相比R-CHOP可显著延长套细胞淋巴瘤患者的总体存活期, objectType=article, longId=152211, objectId=8ea2152211a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea2152211a2, replyNumber=0, likeNumber=79, createdTime=2018-11-24, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea2152211a2, moduleTitle=Lancet oncol：VR-CAP疗法相比R-CHOP可显著延长套细胞淋巴瘤患者的总体存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea2152211a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898010, encodeId=ea88189801012, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=NEJM：Glecaprevir-Pibrentasvir治疗HCV1或3型感染, objectType=article, longId=127679, objectId=1b0712e679e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b0712e679e0, replyNumber=0, likeNumber=71, createdTime=2018-09-07, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b0712e679e0, moduleTitle=NEJM：Glecaprevir-Pibrentasvir治疗HCV1或3型感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b0712e679e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898012, encodeId=298f1898012c1, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果, objectType=article, longId=129002, objectId=6d3e1290027e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d3e1290027e, replyNumber=0, likeNumber=69, createdTime=2018-09-08, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d3e1290027e, moduleTitle=N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d3e1290027e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898003, encodeId=8e43189800328, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Integra Holdings, 生命科学, 融资, 淡马锡, Arie Capital, objectType=article, longId=115672, objectId=e5ee1156e239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5ee1156e239, replyNumber=0, likeNumber=57, createdTime=2018-07-18, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5ee1156e239, moduleTitle=Integra Holdings, 生命科学, 融资, 淡马锡, Arie Capital, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5ee1156e239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898006, encodeId=4a481898006f3, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=2017 CAP指南：头颈部恶性肿瘤患者人类乳头瘤病毒检测, objectType=article, longId=124179, objectId=1a9e1241e9a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9e1241e9a6, replyNumber=0, likeNumber=35, createdTime=2018-06-12, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9e1241e9a6, moduleTitle=2017 CAP指南：头颈部恶性肿瘤患者人类乳头瘤病毒检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9e1241e9a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898008, encodeId=8efc1898008ca, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Medscape公布2017年更佳医生为什么是他们？, objectType=article, longId=124818, objectId=87c612481815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87c612481815, replyNumber=0, likeNumber=63, createdTime=2018-05-15, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87c612481815, moduleTitle=Medscape公布2017年更佳医生为什么是他们？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87c612481815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898001, encodeId=1f0a189800159, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Lancet：Rucaparib可用于经铂类化疗后缓解的复发性卵巢癌患者的维持治疗。, objectType=article, longId=112754, objectId=8d18112e5477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d18112e5477, replyNumber=0, likeNumber=58, createdTime=2018-06-29, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d18112e5477, moduleTitle=Lancet：Rucaparib可用于经铂类化疗后缓解的复发性卵巢癌患者的维持治疗。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d18112e5477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898007, encodeId=b9ef189800ef2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=J Endod：植入二甲基乙二酰甘氨酸的聚乙烯(ε-caprolactone)纤维网可以促进人牙髓来源细胞的成牙本质分化, objectType=article, longId=124669, objectId=750412466912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=750412466912, replyNumber=0, likeNumber=72, createdTime=2018-08-20, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=750412466912, moduleTitle=J Endod：植入二甲基乙二酰甘氨酸的聚乙烯(ε-caprolactone)纤维网可以促进人牙髓来源细胞的成牙本质分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=750412466912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898004, encodeId=77e018980041b, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=eLife：通过RNF145依赖性SCAP泛素化抑制胆固醇生物合成, objectType=article, longId=118560, objectId=88ef1185609d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ef1185609d, replyNumber=0, likeNumber=75, createdTime=2018-08-21, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ef1185609d, moduleTitle=eLife：通过RNF145依赖性SCAP泛素化抑制胆固醇生物合成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ef1185609d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898000, encodeId=310d18980004d, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=【ESC 2017】CAPTAF：导管消融比药物更能提高房颤患者的生活质量, objectType=article, longId=111547, objectId=859811154edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=859811154edc, replyNumber=0, likeNumber=50, createdTime=2018-04-29, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=859811154edc, moduleTitle=【ESC 2017】CAPTAF：导管消融比药物更能提高房颤患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=859811154edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1897997, encodeId=6947189e99788, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Medscape：靠8杯水减肥的童鞋，你瘦了吗？, objectType=article, longId=107757, objectId=13b210e75798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13b210e75798, replyNumber=0, likeNumber=102, createdTime=2017-12-17, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13b210e75798, moduleTitle=Medscape：靠8杯水减肥的童鞋，你瘦了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13b210e75798)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAP

2020-05-29

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

FDA认定rucaparib作为前列腺癌突破性疗法资格

2018-12-05

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能

2019-05-09

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Medscape：风险工具可能有助于确定哪些肺结节是恶性结节？

2018-07-16

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI

2018-07-16

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Medscape盘点｜2018年度心血管领域的Top研究

2019-10-07

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

血检无异常的酒后腹痛，背后暗藏“杀机”！| Medscape病例分享

2019-10-20

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Arch Pathol Lab Med.:CAP/IASLC/AMP发布更新的肺癌患者分子检测

2018-11-07

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

ANN ONCOL：MiCaP模型可以预测前列腺癌患者术后结局

2019-03-08

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

J Hepatol：当无创CAP“遇见”酒精性脂肪肝，不仅诊断准确性高，而且…

2018-07-10

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Lancet oncol：VR-CAP疗法相比R-CHOP可显著延长套细胞淋巴瘤患者的总体存活期

2018-11-24

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

NEJM：Glecaprevir-Pibrentasvir治疗HCV1或3型感染

2018-09-07

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果

2018-09-08

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Integra Holdings, 生命科学, 融资, 淡马锡, Arie Capital

2018-07-18

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

2017 CAP指南：头颈部恶性肿瘤患者人类乳头瘤病毒检测

2018-06-12

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Medscape公布2017年更佳医生为什么是他们？

2018-05-15

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Lancet：Rucaparib可用于经铂类化疗后缓解的复发性卵巢癌患者的维持治疗。

2018-06-29

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

J Endod：植入二甲基乙二酰甘氨酸的聚乙烯(ε-caprolactone)纤维网可以促进人牙髓来源细胞的成牙本质分化

2018-08-20

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

eLife：通过RNF145依赖性SCAP泛素化抑制胆固醇生物合成

2018-08-21

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

【ESC 2017】CAPTAF：导管消融比药物更能提高房颤患者的生活质量

2018-04-29

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Medscape：靠8杯水减肥的童鞋，你瘦了吗？

2017-12-17

科室
- - 订阅+
  - 更多科室
工具
服务